🇺🇸 FDA
Pipeline program

BNT111

BNT111-01

Phase 2 mab completed

Quick answer

BNT111 for Melanoma Stage III is a Phase 2 program (mab) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Melanoma Stage III
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials